InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, will participate in the 5CC (5 Continent-Congress) in the field of medical and aesthetic dermatology.
YOQNEAM, Israel, Aug. 27, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, will participate in the 5CC (5 Continent-Congress) in the field of medical and aesthetic dermatology. The international congress will take place in Barcelona, Spain from August 30 to September 1, 2019. InMode Spain, the company’s newly established Spanish subsidiary, will spearhead the activities at the conference including its speakers and exhibition booth. Drs. Arroyo and Estrada from Spain will be presenting the latest data on Votiva, InMode’s breakthrough technology for feminine wellness and genital treatments. In addition, InMode luminaries from the United States, will travel to present their clinical research regarding InMode’s minimally invasive and non-invasive aesthetic technologies. “The market in Spain has embraced InMode’s innovative technologies and we intend to become the market leader in aesthetic medical procedures,” said Clara Pueyo, General Manager, InMode Spain. “The 5CC is an excellent opportunity to expose both the local and international markets to the latest clinical data on InMode’s growing product suite.” Moshe Mizrahy, InMode CEO, added, “The establishment of InMode Spain is another step forward in our multi-year plan to expand direct sales and marketing channels in key countries by forming subsidiaries. In the past year we’ve expanded sales and marketing activities in Latin America, for example, including participation in aesthetic and dermatology conferences in Mexico and Chile.” About 5CC International Conference About InMode Press Contact: Investor Contact:
SOURCE InMode | ||
Company Codes: NASDAQ-NMS:INMD |